Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Human Models of Selective Insulin Resistance: Alpelisib, Part I

NCT06354088 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT06354088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06354088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Lead sponsor
Columbia University
Phase
Phase 1
Overall status
Recruiting
Start date
April 24, 2024
Completion date
December 31, 2026
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, non-alcoholic fatty liver disease, overweight and obesity, prediabetic state